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Abstract.  We have investigated the mechanisms 
regulating the clustering of nicotinic acetylcholine 
receptor (AChR) on the surface of cultured embryonic 
chick muscle cells. Treatment of these cells with the 
phorbol ester 12-0-tetradecanoylphorbol-13-acetate 
(TPA), a potent activator of protein kinase C, was 
found to cause a rapid dispersal of AChR clusters, as 
monitored by fluorescence microscopy of cells labeled 
with tetramethylrhodamine-conjugated  tz-bungarotoxin. 
The loss of AChR clusters was not accompanied by an 
appreciable change in the amount of AChR on the sur- 
face of these cells, as measured by the specific binding 
of ['251]Bgt. Analysis of the phosphorylation pattern of 
immunoprecipitable AChR subunits showed that the 
?- and 5-subunits are phosphorylated by endogenous 
protein kinase activity in the intact muscle cells, and 
that the 8-subunit displays increased phosphorylation 
in response to TPA. Structural analogues of TPA 
which do not stimulate protein kinase C  have no effect 
on AChR surface topography or phosphorylation.  Ex- 
posure of chick myotubes to the cholinergic agonist 
carbamylcholine was found to cause a dispersal of 
AChR clusters with a time course similar to that of 
TPA.  Like TPA, carbamylcholine enhances the phos- 
phorylation of the 5-subunit of AChR. The carba- 
mylcholine-induced redistribution and phosphorylation 
of AChR is blocked by the nicotinic AChR antagonist 
d-tubocurarine.  TPA and carbamylcholine have no 
effect on cell morphology during the time-course of 
these experiments.  These findings indicate that cell 
surface topography of AChR may be regulated by 
phosphorylation of its subunits and  suggest a mech- 
anism for dispersal of AChR clusters by agonist 
activation. 
I 
T is known that  surface membranes in many cell types 
contain  localized  patches with a macromolecular com- 
position and functional  characteristics  that  are clearly 
distinguishable  from the cell surface in surrounding  regions 
(for examples see references  26 and 27). A well-studied  ex- 
ample of a regional  cell surface specialization  is the motor 
end plate of skeletal muscle cells (for review see references 
20 and 53). A major component of the postsynaptic  muscle 
membrane is the nicotinic acetylcholine receptor (AChR), an 
integral  membrane protein that binds the neurotransmitter 
acetylcholine and transduces  this  binding  into a change in 
membrane permeability.  Before innervation,  AChR is dis- 
tributed homogeneously on the surface of embryonic muscle 
cells.  After  innervation,  the entire  AChR population  be- 
comes concentrated  into a small patch of membrane adjacent 
to the nerve ending  (23).  Although  comprising a focus of 
current research, the structural  mechanisms responsible for 
the formation and maintenance  of high density AChR aggre- 
gates are not adequately  understood.  Recent studies  have 
shown that AChR clusters are attached to the detergent resis- 
tant cytoskeleton  (48, 49, 57), immobilized in the plane  of 
the membrane (4,  57), and spatially  associated with cyto- 
skeletal structures enriched in actin, vinculin,  ~t-actinin, and 
other proteins (8-10,  44). 
Since AChR cell  surface topography  is  under  dynamic 
control in cultured muscle cells, this system has proven ad- 
vantageous for studying the regulation of AChR surface dis- 
tribution.  As in the intact system, innervation of muscle cells 
in  culture  triggers  the  redistribution  of existing  surface 
AChR into high density clusters  subjacent to nerve endings 
(3, 20). Even in aneurally cultured embryonic muscle cells, 
surface AChR spontaneously aggregates to form high density 
clusters (3, 24, 54, 60). Rapid AChR clustering  can be in- 
duced by extracts of neuronal cells (17, 32, 40, 41, 45, 46, 48, 
54). In addition,  AChR clustering is reversible:  rapid disper- 
sal of clusters has been observed upon depletion of extra- 
cellular  Ca  2+  (6,  15),  addition  of the  metabolic  inhibitor 
sodium azide (5),  or exposure to the AChR activator  car- 
bamylcholine (7,  11). 
Tumor-promoting phorbol esters such as 12-0-tetradecanoyl- 
phorbol-13-acetate  (TPA) have been shown to exert marked 
effects on plasma membrane organization  and cytoskeletal 
properties (12, 34, 55). These agents are thought  to act by 
binding  to a  specific  intracellular  receptor,  Ca2+-phospho  - 
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ulating the phosphorylation of its protein targets (16, 38). 
There is evidence that protein kinase C can modulate func- 
tional properties of several types of surface receptors includ- 
ing AChR (1, 22, 38). 
In the present study, we have examined the effects of phor- 
bol esters and the AChR activator carbamylcholine on the 
surface distribution and the phosphorylation state of AChR. 
We have observed that both treatments trigger the redistribu- 
tion of surface AChR from cluster domains, and that in both 
cases the rapid dispersal of clustered AChR is associated 
with an increase in AChR phosphorylation. These findings 
indicate that AChR topology is influenced by protein phos- 
phorylation and suggest a mechanism for the regulation of 
AChR topology. 
Materials and Methods 
Reagents 
nPi  waS  purchased  from  ICN  Radiochemicals  (Irvine,  CA).  [J25I]0t- 
bungaroloxin (Bgt) t and '25I-protein  A were purchased from New England 
Nuclear (Boston, MA). Protein A-Sepharose was purchased from Pharma- 
cia Biotechnology, Inc. (Piscataway, NJ). Tetrametbylrhodamine was pur- 
chased from Kramer Labs (New York, NY). Chemicals for PAGE and West- 
ern blotting were obtained from Bio-Rad Laboratories (Richmond, CA). 
ct-bungarotoxin was obtained  from Boehringer-Mannheim (Indianapolis, 
IN).  All other reagents were from Sigma Chemical Co. (St.  Louis, MO). 
Cell Cultures 
Myogenic cells were isolated from breast muscle tissue of 12-d chick em- 
bryos (50). Cells were plated on collagen-coated culture dishes at an initial 
density of 1.8  x  106 cells/60-mm culture dish.  Cultures were grown in 
DME, supplemented with 10 % horse serum and 2 % chick embryo extract 
at 37°C in an atmosphere of 92% air/8%  CO2. 
Embryonic chick brain extract (BE) prepared from brains of 12-d chick 
embryos as described (32), was added to cultures to stimulate the formation 
of surface clusters of AChR. This extract which contained ".,5 mg/ml protein 
was stored at -70°C until use, and added to cultures at a dilution of 10% 
at l-d and 2-d postplating. Both the amount of surface AChR and the number 
of clusters were enhanced 2-3 fold in BE-treated cultures relative to un- 
treated cells. TPA was prepared as a  100 ltg/ml stock in DMSO, and added 
directly to cultures at a final concentration of 100 riM. The equivalent con- 
centration of DMSO was added to control cultures and had no effect on 
AChR cluster stability or 32p~ incorporation. 
Surface-labeling of  AChR 
AChR on the surface of intact cultured muscle cells was monitored by the 
binding of a-Bgt, as described previously (47, 50). For localization of AChR 
clusters by fluorescence microscopy, Bgt conjugated to tetramethylrhoda- 
mine (TMR-Bgt, 51) was used. [t25I]Bgt was used for quantification of sur- 
face  AChR.  Cultures  were  washed once  in  DME  and  incubated  with 
TMR-Bgt or ['25I]Bgt (10  -8 M) in DME containing BSA (1 mg/ml) for 1 h 
at 37°C. The labeling period was terminated by five washes with 3 ml vol 
of DME to remove unbound toxin. Nonspecific binding was established by 
measuring [~25I]Bgt binding in the presence of the competitive inhibitor 
decamethonium (20 p.M) as described (50), and did not exceed 5 % of total 
labeling. The degradation rate of AChR was measured with  [l:SIlBgt-la- 
beled cultures by monitoring the release of 125I into the medium (21).  Ra- 
dioactivity was measured by dissolving the cells in 1% Triton X-100 in 1 N 
NaOH and gamma counting. 
Fluorescence Microscopy 
Cell surface distribution of AChR was visualized by labeling cultured mus- 
cle cells with TMR-Bgt and inspecting the fixed cultures with a Zeiss pho- 
1. Abbreviations used in this paper: BE, chicken embryo brain extracts; Bgt, 
ct-bungarotoxin; TMR, monotetramethylrhodamine. 
tomicroscope equipped with epi-illumination and the appropriate excitation 
and emission filters. After TMR-Bgt labeling was carried out as described 
above, cells were fixed with 3.7%  formaldehyde in PBS for 20 min on ice, 
rinsed with water, and mounted with aquamount. Nonspecific staining in 
the presence of decamethonium (10  -5  M) yielded very low  background 
fluorescence. As described previously by ourselves (49) and others (3-8, 
42, 53), AChR clusters are easily distinguished in TMR-Bgt-labeled cul- 
tures as discrete patches of intense fluorescence. These can be present on 
either the upper or the lower surface of myotubes, and are consistent in ap- 
pearance and dimensions, displaying a circular to elliptical shape with an 
average area of ,,o 35-55 I.tm  2 and a diameter of 15-20 ~tm. For each deter- 
mination, clusters on myotubes in 50 randomly-selected fields were viewed 
by fluorescence microscopy and counted. 
Preparation of  Antisera 
Rabbit  antiserum was prepared  against the et-  and  6-subunits of AChR 
purified by affinity chromatography from denervated leg muscle of adult 
chicken  as  detailed  elsewhere  (52).  AChR  subunits were  resolved  by 
SDS-PAGE (33) and identified by immunoblotting as described elsewhere 
(52) and shown in Fig.  1. The specificity of this antiserum was established 
by  immunoblotting to  extracts  of cultured muscle cells  fractionated  on 
SDS-polyacrylamide gels and transferred to  nitrocellulose.  Under these 
conditions the anti-6-antiserum recognized only the 6-subunit and did not 
react with the other AChR subunits or with other proteins (52). 
Labeling, lmmunoprecipitation, and lmraunoblotting 
Cultures were  labeled  at  37°C  with  [nP]orthophosphate (2  mCi/ml) in 
phosphate-free medium for 4  h.  Labeling was terminated by two washes 
with a solution consisting of 150 mM NaCl,  10 mM Tris, pH 7.4, 2  mM 
EGTA, and 2 mM EDTA, 5 mM benzamidine, 1 mM phenylmethylsulfonyl 
fluoride (PMSF),  1% aprotiniu,  10 tzg/ml leupeptin, l0 mM n-ethylmalei- 
mide, 50  mM sodium fluoride, 40 mM sodium pyrophosphate, 20 mM 
potassium phosphate,  l0 mM sodium molybdate, and  1 mM sodium or- 
thovanadate (Buffer A). These washes and subsequent steps were carried out 
at 4°C. Cells were scraped with a rubber policeman, pelle~:l by centrifuga- 
tion, and extracted for 30 rain in Buffer A containing 0.5% Triton X-100 (a 
procedure that solubilizes total cellular AChR as monitored in [z25I]Bgt-la- 
beled cultures). The extracts were clarified by centrifugation at 100,000  g 
for 30 min. The supernatants were incubated with anti-6 antisera for 3 h, 
then with Protein A-Sepharose beads for 1 h. The precipitates were washed 
five times with Buffer A and resuspended in 50 gl of SDS sample buffer. 
After incubation for 10 min at room temperature the beads were centrifuged 
and the supernatants were fractionated on  10%  SDS-polyacrylamide gels 
according to Laemmli (33). The gels were stained with Coomassie Brilliant 
Blue, destained and exposed to Kodak XAR-5 X-ray film for 24-48 h. For 
immunoblotting experiments,  AChR was  purified  by  batchwise  affinity 
chromatography on cobra toxin-sepharose. Samples were fractionated by 
SDS-PAGE and the proteins were transferred to nitrocellulose paper and 
visualized by labeling with the specified antisera and  '25I-protein  A. 
Results 
Cultured embryonic chick muscle cells that were treated 
with BE displayed prominent surface clusters of AChR at 5-d 
postplating, as visualized by the fluorescence staining of in- 
tact cells with TMR-Bgt (Figs.  1 A and 2 A). Shown in Figs. 
1 B and 2 B are similar fields after incubation for l0 h in 
growth medium containing 100 nM TPA.  As  shown, this 
TPA treatment resulted in a marked decrease in the number 
of AChR clusters.  This effect was  not accompanied by a 
significant change in cell morphology within the time course 
of  these experiments (Figs. 1 and 2). Surface levels of  AChR, 
determined by the specific  binding of [tESI]Bgt, did not de- 
crease significantly  during TPA incubation periods sufficient 
to cause marked cluster loss (Table I).  During an 8-h ex- 
posure to TPA, AChR levels decreased by less than 15 % (Ta- 
ble I), whereas the number of AChR clusters decreased by 
greater than 70% (Fig. 3 A). This suggests that TPA-induced 
cluster loss reflects a  lateral redistribution of cell surface 
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image of TMR-Bgt-labeled untreated myotube. (B) Myotube from 
a replicate culture after a 6-h exposure to TPA (100 nM). Bar, 10 ~tm. 
Figure 1. Effect of TPA on distribution of AChR on the surface of 
cultured muscle ceils. Cells were stained with TMR-Bgt and fixed 
as described  in Materials  and Methods.  (A) Fluorescent  image of 
untreated cultures on which numerous AChR clusters are visible. 
(B) Cultures  after a  10-h exposure  to TPA (100 nM).  Note the 
decrease  in number of AChR clusters.  Bar, 50 ~m. 
AChR. Supporting this possibility is our observation that the 
dispersal of AChR clusters in TPA-treated cultures  is  fre- 
quently  accompanied by an  increase  in  diffuse  TMR-Bgt 
labeling. 
The loss of AChR clusters caused by exposure of myotubes 
to  100  nM TPA was quantified by counting the number of 
clusters per myotube at increasing times after TPA addition. 
When  these data  were plotted on a  semilogarithmic scale 
(Fig.  3 A) and analyzed as described (56),  the points were 
well fit by a simple linear regression. In addition, an analysis 
of residual autocorrelation (13) shows that a linear model of 
these data is appropriate. The loss of AChR clusters from the 
surface of myotubes exposed to TPA occurs with a half-time 
of ".~4.5 h, as obtained from the slope of the linear plot (Fig. 
3 A). In contrast, no time-dependent loss of AChR clusters 
was observed in replicate cultures that were treated with 100 
nM  phorbol-12,13-diacetate,  a  structural  analogue of TPA 
that is biologically inactive (12,  16).  A  line drawn with the 
aid of a computer to fit the points representing the number 
of clusters  per  myotube at  different  times  of exposure to 
phorbol-12,13-diacetate (Fig. 3 A, open circles) gave a slope 
not significantly different from zero (P > 0.6).  Moreover, we 
observed that dioctanylglycerol (0.1 mM), a cell-permeable 
diacylglycerol that is structurally different than TPA yet is an 
efficient activator of protein kinase C in cultured cells (19), 
mimics TPA in causing the time-dependent dispersal of AChR 
clusters (not shown).  These data support a  role for protein 
kinase C  in AChR cluster dispersal. 
Exposure  to  the  AChR  activator  carbamylcholine  was 
reported to  cause dispersal  of AChR  clusters  from mem- 
branes of cultured rat myotubes (7) as well as at developing 
rat neuromuscular junctions  (11). We have found that car- 
bamylcholine also  causes  the  declustering  of cell  surface 
AChR in chick muscle cultures, and have compared this ac- 
tion of carbamylcholine with the effects of TPA. BE-treated 
Table L Effects of TPA and Carbachol on AChR Levels in Cultured Muscle Cells 
[~Z~l]Bgt binding  Percentage of control 
Incubation time  0. 5  h  3. 0  h  8. 0  h 
Experimental condition 
TPA  102  +  3.46 (6)  88  +  1.0 (3)  88 +  2.74 (6) 
Carbachol  93  +  5.66 (6)  87  +  3.32 (5)  77  +  8.67 (6) 
Cultures were incubated at 37°C in growth medium with or without TPA (100 nM) or carbamylcholine  (1  mM) for the time specified. The cultures were then 
washed extensively and labeled with [~25I]Bgt (10  -8 M) for  I h at 37°C as described  in Materials and Methods.  Values represent  mean  +_  SD, followed by the 
number of determinations,  in parentheses. 
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creasing intervals, then washed five times with fresh medium 
to remove carbamylcholine and labeled with TMR-Bgt. The 
time-dependence of AChR cluster dispersal induced by car- 
bamylcholine is shown in Fig. 3 B. As in the case of TPA- 
induced cluster dispersal (Fig. 3 A), the data were adequately 
fit by a  simple linear regression determined by computer 
analysis. Upon comparison of the slopes of the linear plots 
of AChR cluster dispersal induced by TPA and carbamylcho- 
line, an analysis of covariants indicates that the 2 slopes are 
not  significantly different from  each  other  (the  common 
slope is 0.131; P > 0.58). Since the slope corresponds to the 
rate constant, these results indicate that TPA and carbamyl- 
choline induce AChR cluster dispersal at similar rates, with 
similar half times of 4-5 h. 
The marked loss of AChR clusters induced by carbamyl- 
choline was found not to be associated with significant mor- 
phological changes showing that the loss of clusters is not a 
secondary consequence of altered cell shape, in agreement 
with  previous findings  (7).  The carbamylcholine-induced 
dispersal of AChR clusters is accompanied by a small de- 
crease in surface labeling by [125I]Bgt (Table I).  After 30 
min  in  carbamylcholine,  [~25I]Bgt levels  are  reduced  by 
5-10%, possibly due to persistent presence of carbamylcho- 
line acting as a competitive inhibitor of Bgt binding.  Over 
the next 7.5 h in carbamylcholine surface [~25I]Bgt labeling 
decreases  an  additional  10-15%.  A  carbamylcholine-in- 
duced decline of AChR has previously been shown to occur 
in mouse (39) and chick (25) muscle cells. Carbamylcholine- 
induced cluster loss, then, may result from either a lateral 
redistribution of AChR from clustered to diffuse areas,  as 
happens with TPA, or by an internalization of AChR which 
results in a loss of surface AChR clusters. The first possibil- 
ity is supported by our observation that the time course of 
cluster loss is similar in TPA and carbamylcholine-treated 
cultures (Fig. 3). To test the possibility that cluster dispersal 
reflects the internalization of cell surface AChR,  cultures 
were labeled for 1 h with TMR-Bgt, and subsequently in- 
cubated at 37°C for 8 h before cell fixation and visualization 
of AChR by fluorescence microscopy. During this interval la- 
beled cell surface AChR was diminished ,~30% due to nor- 
mal internalization and degradation. Although under these 
conditions the decrease in labeled cell surface AChR exceeds 
the decrease observed after an 8-h incubation in carbamyl- 
choline,  the  number  of clusters  was  not  decreased  (not 
shown). The loss of clusters induced by carbamylcholine or 
TPA was not associated with a change in metabolic degrada- 
tion rates of AChR (not shown). Although it is possible that 
clustered AChR is selectively internalized in carbamylcho- 
line-treated cultures, we have no evidence that this occurs. 
To determine if the induction of AChR cluster dispersal by 
carbamylcholine was related to the direct action on AChR of 
this agonist, these experiments were repeated in the presence 
of the competitive inhibitor d-tubocurarine (open circles in 
Fig.  3 B).  As shown,  the presence of d-tubocurarine pre- 
vented the dispersal by carbamylcholine of surface AChR 
clusters. Thus carbamylcholine must bind to AChR to cause 
cluster dispersal,  in agreement with  recent findings in rat 
myotubes (7), showing that carbamylcholine caused AChR 
cluster loss via the activation of AChR. 
Recent evidence indicates that TPA exerts its effects by ac- 
tivation of protein kinase C at the surface membrane (38). 
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Figure 3. The time course of AChR cluster loss in the presence of 
TPA and carbamylcholine. (.4) Cultures were incubated with 100 
nM TPA (closed circles) or 100 nM phorbol-12,13-diacetate (open 
circles) for the indicated times. (B) Cultures were incubated for the 
indicated times with 1 mM carbamylcholine (closed circles) or with 
1 mM carbamylcholine plus 1 mM d-tubocurarine after a 20-min 
preincubation with d-tubocurarine alone (open circles). Cultures 
were stained with TMR-Bgt and fixed, and clusters per myotube 
were counted as described in Materials and Methods. Lines were 
drawn with the aid of a computer as described in Materials and 
Methods. 
In doing so, TPA substitutes for the endogenous activator of 
this  enzyme,  diacylglycerol, that  is  transiently  produced 
through phospholipase C-catalyzed hydrolysis of phosphati- 
dylinositol bisphosphate (38). This pathway is activated by 
a number of hormones and neurotransmitters and constitutes 
a  mechanism for transmembrane signal transduction (38). 
Recent findings indicate that activation of nicotinic AChR in 
cultured muscle may stimulate this pathway and cause activa- 
tion of protein kinase C  (1, 22).  AChR from Torpedo  has 
been reported to be a substrate for protein kinase C (14, 30). 
These considerations led us to investigate the possibility that 
TPA and carbamylcholine induce AChR phosphorylation in 
intact muscle cells. 
Cultures were labeled with [3~p]orthophosphate,  extracted, 
and immunoprecipitated with antisera directed against the 
8-subunit of chick muscle AChR as detailed under Materials 
and Methods. The immunoprecipitates were fractionated by 
SDS-PAGE and 32prlabeled polypeptides were visualized 
by autoradiography. The fractionation pattern of AChR sub- 
units was established by immunoblotting as described else- 
where  (52).  As  shown  in  Fig.  4  A,  the  tt-subunit  was 
identified in immunoblots as a 40-kD peptide by binding of 
J25I[Bgt] (lane  1)  and  anti-a-subunit  antiserum  (lane 2). 
Similarly, the 5-subunit was identified by the binding of  anti- 
fi-subunit antiserum (lane 3).  We have observed that two 
phosphorylated AChR  peptides,  the  8-subunit  (Mr  =  55 
kD) and the y-subunit (M,  =  50 kD), are immunoprecipi- 
tated by Bgt-anti Bgt (Fig. 4 B, lane 1 ) and mAb 35 (Fig. 
4 B, lane 3), as well as by other anti-AChR antisera.  The 
y-subunit is coimmunoprecipitated under nondenaturing con- 
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as 7- (rather than 13-) is more tentative (52). 
As can be seen in Fig. 5, a 30-min exposure of the intact 
myotubes to either 100 nM TPA (lane 2) or 1 mM carbamyl- 
choline (lane 3)  resulted in  a  dramatic  increase  in  phos- 
phorylation of the 8-subunit (upper arrow). This subunit, in 
contrast to the 7-subunit, contains a potential phosphoryla- 
tion site for protein kinase C  (30,  36). In addition, a slight 
stimulation of 7-subunit phosphorylation was  seen in car- 
bamylcholine treated  cells  (lane  3).  The  increased  phos- 
phorylation of the 6-subunit was detected within 5-10 min 
of addition of carbamylcholine or TPA  (not shown).  The 
effect of TPA on AChR phosphorylation was reproduced by 
the cell-permeable diacylglycerol dioctanoylglycerol, while 
no change in phosphorylation state was observed when cells 
were treated with the inactive phorbol ester phorbol-12,13- 
diacetate (not shown).  Moreover, the presence of d-tubo- 
curarine was found to prevent the enhanced phosphorylation 
induced by carbamylcholine. Thus, AChR cluster dispersal 
by activators of either protein kinase C or AChR is accompa- 
nied by increased AChR subunit phosphorylation. 
Discussion 
Several lines of evidence suggest that the TPA-induced AChR 
cluster dispersal  and the increased AChR phosphorylation 
observed in the present study both result from activation of 
protein kinase C. Cluster dispersal is not induced by phorbol 
diacetate (Fig.  3  A),  a  structural  analogue of TPA that  is 
ineffective as a tumor promoter and does not activate protein 
kinase C (16). Conversely, the cell permeable diacylglycerol 
dioctanylglycerol, a potent activator of protein kinase C (19) 
that is structurally distinct from phorbol esters, mimics the 
actions of TPA on both the surface distribution and phos- 
phorylation of AChR. Moreover, the effects of TPA on both 
AChR phosphorylation and cell surface distribution are ex- 
erted  rapidly.  Increased  phosphorylation can  be detected 
within 5 min of TPA addition, and the decrease in the num- 
Figure 4. Identification and phosphorylation of AChR subunits in 
cultured chick muscle cells. (,4)  Overlay of blots of partially purified 
AChR from cultured chick muscle with [m25I]Bgt  (lane 1), anti- 
¢t-subunit antiserum (lane 2), and anti-5-subunit  antiserum (lane 
3). Bound immunoglobulins in lanes 2 and 3 were visualized by 
~25I-protein A autoradiography. (B) 32Pi-labeled cultures extracted 
and immunoprecipitated with Bgt anti-Bgt (lane 1); Bgt anti-Bgt 
using anti-Bgt which was preabsodxxt with free Bgt (lane 2); mAb35 
(lane 3); mAb35 preabsorbed with purified Torpedo AChR (lane 
4). Note that the 5- and 7-subunits are visible as phosphoproteins 
of 55- and 50-kD, respectively. 
Figure 5. Effects  of TPA and carbamylcho- 
line  on  phosphorylation  of AChR sub- 
units. Cultures were labeled at 37°C with 
[32P]-orthophosphate  (2  mCi/ml)  in 
phosphate-free medium for 4 h. Cultures 
were exposed to 100 nM TPA or 1 mM 
carbamylcholine for the final 30 min, then 
rinsed and extracted as described in Materials and Methods. The 
extracts were immunoprecipitated with antisera against 5-subunit, 
and immunoprecipitates were resolved by SDS-PAGE and radio- 
autography. (Lane 1 ) control; (lane 2) TPA; (lane 3) carbamylcho- 
line; (lane 4) preimmune serum.  Upper arrow shows 5-subunit. 
Lower arrow indicates 7-subunit. 
ber of clusters per myotube is significant within 30 min. In 
addition,  the dispersal  of individual  receptors may occur 
considerably earlier than the measurable loss of AChR clus- 
ters.  Thus the time course of phosphorylation and cluster 
dispersal  is  consistent with a  mechanism by which phos- 
phorylation induces AChR redistribution. 
There is evidence that the regulation of AChR aggregation 
resides in interactions between surface AChR and protein- 
aceous structures adjacent to the lipid bilayer, including the 
cytoskeleton and the extracellular matrix.  There is a good 
possibility that AChR surface topology is controlled via in- 
teractions with the cytoskeleton. AChR in clusters is selec- 
tively anchored to the detergent-insoluble cytoskeletal frame- 
work (48,  49, 57), laterally immobile (4, 58) and spatially 
associated with underlying cytoskeletal foci displaying ele- 
vated concentrations of actin  (10),  vinculin (8),  0t-actinin 
(9), and a postsynaptic 43-kD protein (44). Electron micro- 
scopic studies have shown that filamentous components of 
the cytoskeleton directly underlie AChR aggregates in cul- 
tured muscle (43), Torpedo electroplax (28), and neuromus- 
cular junctions (29). TPA treatment of cultured kidney cells 
has been reported to cause the rapid redistribution of sub- 
membrane actin, ¢t-actinin and vinculin (34, 55). Thus, it is 
possible that AChR cluster dispersal that we have observed 
in TPA-treated myotubes is a consequence of the reorganiza- 
tion of these submembranal cytoskeletal elements triggered 
by  phorbol  ester.  The  protein  kinase  C-catalyzed  phos- 
phorylation of myosin was shown to inhibit myosin-actin in- 
teraction (37) and consequently could induce reorganization 
of microfilament based cytoskeletal structures involved in an- 
chorage of aggregated AChR. 
An alternative possibility is  that the dispersal  of AChR 
clusters by TPA is a more direct consequence of the stimu- 
lated phosphorylation of AChR which we have observed to 
occur under these conditions (Fig. 5). Based on the location 
of potential phosphorylation sites for several protein kinases 
including protein kinase C on a putative cytoplasmic domain 
of AChR subunits, Browning et al. (14) have suggested that 
phosphorylation could regulate cytoskeletal associations and 
clustering of AChR.  It is noteworthy that the 8-subunit of 
chick AChR possesses a  potential phosphorylation site for 
protein kinase C (30, 36) and it is this subunit which has en- 
hanced phosphorylation in response to TPA. 
A major finding of this study is that carbamylcholine, an 
AChR activator, causes a marked elevation of AChR phos- 
phorylation. This observation supports a role for phosphory- 
lation in AChR autoregulatory mechanisms, as has been sug- 
gested  by  recent  findings  implicating  phosphorylation in 
Ross et al. Regulation of AChR Surface Distribution  1143 modulating AChR desensitization by activators (2, 22, 31, 35). 
Our present findings indicate that AChR activators may in- 
fluence AChR surface topography through phosphorylation- 
dephosphorylation mechanisms. The ability of the competitive 
inhibitor d-tubocurarine to block both AChR phosphoryla- 
tion and cluster dispersal induced by carbamylcholine  indi- 
cates that these effects are directly initiated by agonist action. 
Recent  evidence documents the activation  of second mes- 
sengers by nicotinic AChR agonists. Nicotinic stimulation of 
AChR has been shown to rapidly activate protein kinase C 
in chromaffin cells (59). In addition, in cultured muscle cells 
carbamylcholine  activation  of AChR has been observed to 
stimulate phosphatidylinositol  turnover (1), a physiological 
pathway that leads to protein kinase  C activation  (38). 
The present  study  demonstrates  that both TPA and the 
receptor agonist carbamylcholine  cause elevation of AChR 
phosphorylation  and cluster  dispersal  in cultured  muscle. 
These findings indicate that cellular phosphorylation  mecha- 
nisms can modulate AChR surface distribution. 
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